James Doherty

Acumen Pharmaceuticals, Inc. (ABOS)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About James Doherty

Acumen Pharmaceuticals, Inc. reported in an 8-K filed February 1, 2024 that James Doherty was appointed President and Chief Development Officer, effective February 1, 2024.

“On February 1, 2024, Acumen Pharmaceuticals, Inc. (the "Company") announced that James Doherty has been appointed as its President and Chief Development Officer, effective February 1, 2024.”

Acumen Pharmaceuticals, Inc. Form 8-K, filed February 1, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize James Doherty's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Acumen Pharmaceuticals, Inc. (ABOS)
Source not stated

Current

Company network

Recorded roles and call appearances connecting this person to public companies.

Acumen Pharmaceuticals, Inc.

ABOS

Current role

Leadership on record at Acumen Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Daniel O'Connell CEO
Dr. George Golumbeski Chairman, Board Member
Matthew Zuga CFO
Russell Barton COO
Derrell Porter Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: President and Chief Development Officer Acumen Pharmaceuticals, Inc. (ABOS)
2024-02-01